120 related articles for article (PubMed ID: 27381359)
1. Genetic profile of PTEN gene in Indian oral squamous cell carcinoma primary tumors.
Shah S; Jajal D; Mishra G; Kalia K
J Oral Pathol Med; 2017 Feb; 46(2):106-111. PubMed ID: 27381359
[TBL] [Abstract][Full Text] [Related]
2. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
3. [Mutation and expression of tumor suppressor gene phosphatase and tensin homolog deleted in chromosome 10 in oral squamous cell carcinoma].
Li Q; Zhao JZ; Chen YN; Zhang T; Zhou L; Jin Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Nov; 44(11):660-3. PubMed ID: 20079266
[TBL] [Abstract][Full Text] [Related]
4. PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.
Yang XD; Zhao SF; Zhang Q; Li W; Wang YX; Hong XW; Hu QG
Tumour Biol; 2016 Jan; 37(1):577-82. PubMed ID: 26232326
[TBL] [Abstract][Full Text] [Related]
5. PTEN expression and methylation status in oral squamous cell carcinoma.
Kurasawa Y; Shiiba M; Nakamura M; Fushimi K; Ishigami T; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Oncol Rep; 2008 Jun; 19(6):1429-34. PubMed ID: 18497947
[TBL] [Abstract][Full Text] [Related]
6. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
[TBL] [Abstract][Full Text] [Related]
7. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma.
Baghaei F; Abdollahi A; Mohammadpour H; Jahanbin M; Naseri Taheri F; Aminishakib P; Emami Razavi A; Kharazifard M
J Oral Pathol Med; 2019 Jan; 48(1):31-35. PubMed ID: 30372795
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population.
Shah S; Shah S; Padh H; Kalia K
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):628-35. PubMed ID: 26453385
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.
Cohen Y; Goldenberg-Cohen N; Shalmon B; Shani T; Oren S; Amariglio N; Dratviman-Storobinsky O; Shnaiderman-Shapiro A; Yahalom R; Kaplan I; Hirshberg A
Oral Oncol; 2011 Oct; 47(10):946-50. PubMed ID: 21824802
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter methylation of PTEN gene among Indian
patients with oral squamous cell carcinoma.
Alyasiri NS; Ali A; Kazim Z; Gupta S; Mandal AK; Singh I; Rizvi MA
Int J Biol Markers; 2013 Sep; 28(3):298-302. PubMed ID: 23787493
[TBL] [Abstract][Full Text] [Related]
11. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma.
Chen Q; Samaranayake LP; Zhou H; Xiao L
Oral Oncol; 2000 Jan; 36(1):95-9. PubMed ID: 10889927
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR‑21 promotes cell apoptosis in oral squamous cell carcinoma by upregulating PTEN.
Zheng Y; Xie J; Jiang F; Li Y; Chang G; Ma H
Oncol Rep; 2018 Nov; 40(5):2798-2805. PubMed ID: 30132571
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas.
Shin KH; Kim JM; Rho KS; Park KH; Oh JE; Min BM
Int J Oncol; 2002 Nov; 21(5):997-1001. PubMed ID: 12370746
[TBL] [Abstract][Full Text] [Related]
16. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.
Zhou CX; Gao Y
Oncol Rep; 2007 Jan; 17(1):73-9. PubMed ID: 17143481
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
18. Estimation of vascular endothelial growth factor gene -460 C/T polymorphism as a biomarker in oral squamous cell carcinoma patients from the Indian subcontinent.
Borase AP; Ganvir SM; Hazarey VK; Gosavi SR; Mohatta AA; Singh J
J Investig Clin Dent; 2015 Nov; 6(4):267-72. PubMed ID: 25051952
[TBL] [Abstract][Full Text] [Related]
19. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations of IL-10: Identification of novel variations and evaluation of the impact of the SNPs/haplotype in the promoter region with the progression of Oral Squamous Cell Carcinoma in Indian population.
Sharma U; Singhal P; Bandil K; Kumar A; Bose S; Ahuja P; Kohli M; Dewan AK; Tayal J; Banerjee BD; Prasheri A; Mehrotra R; Sharma V; Bharadwaj M
Cytokine; 2018 Mar; 103():99-108. PubMed ID: 28982581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
